The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Stem cells from bone marrow, skeletal muscle and possibly other tissues can be identified by the 'side-population' (SP) phenotype. Although it has been assumed that expression of ABC transporters is responsible for this phenotype, the specific molecules involved have not been defined. Here we show that expression of the Bcrp1 (also known as Abcg2 murine/ABCG2 human) gene is a conserved feature of stem cells from a wide variety of sources. Bcrp1 mRNA was expressed at high levels in primitive murine hematopoietic stem cells, and was sharply downregulated with differentiation. Enforced expression of the ABCG2 cDNA directly conferred the SP phenotype to bone-marrow cells and caused a reduction in maturing progeny both in vitro and in transplantation-based assays. These results show that expression of the Bcrp1/ABCG2 gene is an important determinant of the SP phenotype, and that it might serve as a marker for stem cells from various sources.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Side population cells express ATP-binding cassette transporter (ABCG2/Brcp1) on the cell surface and have the ability to efflux the DNA binding dye Hoechst 33 342 (Zhou et al., 2001).”
From Endometriosis and nuclear receptors (2019) · cites this paper as Zhou et al., 2001
Citations
Cites
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
Goodell, M. A., Brose, K., Paradis, G., Conner, A. S., & Mulligan, R. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1797 · Cited by 2,903
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Purified hematopoietic stem cells can differentiate into hepatocytes in vivo
Lagasse, E., Connors, H., Al-Dhalimy, M., Reitsma, M., Dohse, M., Osborne, L., Wang, X., Finegold, M., Weissman, I. L., & Grompe, M. (2000) · Nature Medicine · doi:10.1038/81326 · Cited by 2,314
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Self-citationDystrophin expression in the mdx mouse restored by stem cell transplantation
Gussoni, E., Soneoka, Y., Strickland, C. D., Buzney, E. A., Khan, M. K., Flint, A. F., Kunkel, L. M., & Mulligan, R. C. (1999) · Nature · doi:10.1038/43919 · Cited by 1,802
Goodell, M. A., Rosenzweig, M., Kim, H., Marks, D. F., DeMaria, M., Paradis, G., Grupp, S. A., Sieff, C. A., Mulligan, R. C., & Johnson, R. P. (1997) · Nature Medicine · doi:10.1038/nm1297-1337 · Cited by 1,089
A safe packaging line for gene transfer: separating viral genes on two different plasmids
Markowitz, D., Goff, S., & Bank, A. (1988) · Journal of Virology · doi:10.1128/jvi.62.4.1120-1124.1988 · Cited by 1,061
Hematopoietic potential of stem cells isolated from murine skeletal muscle
Jackson, K. A., Mi, T., & Goodell, M. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14482 · Cited by 955
Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A. A. M., van Deemter, L., Smit, J. J. M., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4028 · Cited by 937
Chaudhary, P. M., & Roninson, I. B. (1991) · Cell · doi:10.1016/0092-8674(91)90141-k · Cited by 934
Cited by
Items 901–1,000 of 1,005
Tumor-associated myeloid cells as guiding forces of cancer cell stemness
Sica, A., Porta, C., Amadori, A., & Pastò, A. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-1997-8 · Cited by 49
“Another important defense mechanism exploited by CSCs is their ability to reduce drug accumulation by extruding toxic compound through the expression of ATP-binding cassette transporters, such as ABCG2 or multidrug resistance protein (MDR1, MDR2) [16].”
BackgroundXu, L., Huang, T.-J., Hu, H., Wang, M.-Y., Shi, S.-M., Yang, Q., Lin, F., Qiang, Y.-Y., Mei, Y., Lang, Y., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.016 · Cited by 48
Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases
Roato, I., & Ferracini, R. (2018) · Cancers · doi:10.3390/cancers10020056 · Cited by 50
Ishikawa, T., Sakurai, A., Kanamori, Y., Nagakura, M., Hirano, H., Takarada, Y., Yamada, K., Fukushima, K., & Kitajima, M. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)00027-3 · Cited by 48
Human ABC transporters ABCG2 (BCRP) and ABCG4
Koshiba, S., An, R., Saito, H., Wakabayashi, K., Tamura, A., & Ishikawa, T. (2008) · Xenobiotica · doi:10.1080/00498250801986944 · Cited by 47
Corneal epithelial stem cells in health and disease
Daniels, J. T., Harris, A. R., & Mason, C. (2006) · Stem Cell Reviews and Reports · doi:10.1007/s12015-006-0053-4 · Cited by 47
Scobioala, S., Klocke, R., Kuhlmann, M. T., Tian, W., Hasib, L., Milting, H., Koenig, S., Stelljes, M., El‐Banayosy, A., Tenderich, G., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8252com · Cited by 47
Gene Variants Associated With Ischemic Stroke: The Cardiovascular Health Study
Luke, M. M., O’Meara, E. S., Rowland, C. M., Shiffman, D., Bare, L. A., Arellano, A. R., Longstreth, W. T., Jr., Lumley, T., Rice, K. M., Tracy, R. P., et al. (2008) · Stroke · doi:10.1161/strokeaha.108.521328 · Cited by 50
Bhinge, K. N., Gupta, V. K., Hosain, S. B., Satyanarayanajois, S. D., Meyer, S. A., Blaylock, B. L., Zhang, Q.-J., & Liu, Y. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.06.010 · Cited by 51
“Materials & Methods 2.1 Preparation of bone marrow cells Bone marrow cells (BMCs) were extracted from the femurs of mice under sterile condition, as described previously with minor modification (Zhou et al., 2001).”
BackgroundMethodInfluentialYao, J. J., An, Y., Wie, J., Chen, P., Miao, Y., Ji, Z., Lu, Z. P., Jl, W., Jiang, K., & Xu, Z. (2011) · Swiss Medical Weekly · doi:10.4414/smw.2011.13208 · Cited by 46
van Tellingen, O., Buckle, T., Jonker, J. W., van der Valk, M. A., & Beijnen, J. H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601363 · Cited by 54
Isolation and characterisation of a novel trophoblast side-population from first trimester placentae
James, J. L., Hurley, D., Gamage, T. K. J. B., Zhang, T., Vather, R., Pantham, P., Murthi, P., & Chamley, L. (2015) · Reproduction · doi:10.1530/rep-14-0646 · Cited by 46
“39 Transporter protein characteristic of stem cell populations that is thought to be largely responsible for the increased efflux of Hoechst 33342 (Zhou et al. 2001) TEAD2 7.”
Kharkar, P. S. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01336 · Cited by 47
Umemoto, T., Yamato, M., Shiratsuchi, Y., Terasawa, M., Yang, J., Nishida, K., Kobayashi, Y., & Okano, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7733 · Cited by 46
Pluripotency in Adult Stem Cells: State of the Art
Serafini, M., & Verfaillie, C. M. (2006) · Seminars in Reproductive Medicine · doi:10.1055/s-2006-952153 · Cited by 58
The presence of ABCG2-dependent side population cells in human periodontal ligaments
Kawanabe, N., Murakami, K., & Takano‐Yamamoto, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.237 · Cited by 46
Hooijberg, J. H., de Vries, N. A., Kaspers, G. J. L., Pieters, R., Jansen, G., & Peters, G. J. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0141-1 · Cited by 53
Leon, F., Seshacharyulu, P., Nimmakayala, R. K., Chugh, S., Karmakar, S., Nallasamy, P., Vengoji, R., Rachagani, S., Cox, J. L., Mallya, K. B., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02047-2 · Cited by 45
Chang, C.-Y., McGhee, J. J., Green, C. R., & Sherwin, T. (2011) · Cornea · doi:10.1097/ico.0b013e318213796b · Cited by 45
Stemness and angiogenic gene expression changes of serial-passage human amnion mesenchymal cells
Fatimah, S. S., Tan, G. C., Chua, K. H., Manzor, N. F. M., Tan, A. E., & Hayati, A. R. (2012) · Microvascular Research · doi:10.1016/j.mvr.2012.12.004 · Cited by 45
Park, S. H., Sung, J. H., & Chung, N. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2096-1 · Cited by 45
“A side-population (SP) has been developed for the identification and analysis of CSCs [4].”
Miao, X. (2010) · Oncology Reports · doi:10.3892/or_00000774 · Cited by 45
Ngalame, N. N. O., Makia, N. L., Waalkes, M. P., & Tokar, E. J. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.12.013 · Cited by 46
“ABCG2 plays a role in SC population maintenance and is a marker for prostate SCs and CSCs (Huss et al. 2005; Zhou et al. 2001).”
BackgroundThe Efflux Transporter ABCG2 Maintains Prostate Stem Cells
Sabnis, N. G., Miller, A., Titus, M. A., & Huss, W. J. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0270-t · Cited by 45
“In fact, overexpression of ABCG2 has been shown to promote stemness while the loss of ABCG2 expression has been shown to promote lineage commitment in the retinal, hematopoietic, and cardiac side population cells (1, 2, 7).”
Cheng, C., Yu, J., Hsieh, Y., Liao, W., Shieh, J., Yao, C., Lee, H., Chen, P., Wu, P., & Shen, C. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492561 · Cited by 46
Mouthon, M., Fouchet, P., Mathieu, C., Sii-Felice, K., Etienne, O., Lages, C. S., & Boussin, F. D. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04118.x · Cited by 45
Limbal stem cells, a review of their identification and culture for clinical use
O’Sullivan, F., & CLYNES, M. M. (2007) · Cytotechnology · doi:10.1007/s10616-007-9063-6 · Cited by 45
Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria
Roundhill, E. A., & Burchill, S. A. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.40 · Cited by 45
“Mitochondrial MRP-1 in normal cells was high in MSCs (Figure 2A), consistent with previous reports, suggesting that stem cells express high levels of ABC transport proteins (Zhou et al, 2001; Kim et al, 2002).”
BackgroundResultKobayashi, D., Aizawa, S., Maeda, T., Tsuboi, I., Yabuuchi, H., Nezu, J., Tsuji, A., & Tamai, I. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.08.009 · Cited by 45
Ujhelly, O., Özvegy‐Laczka, C., Várady, G., Cervenak, J., Homolya, L., Grez, M., Scheffer, G. L., Roos, D., Bates, S. E., Váradi, A., et al. (2003) · Human Gene Therapy · doi:10.1089/104303403321209005 · Cited by 45
Cardiac stem cells: Current knowledge and future prospects
Mehanna, R. A., Essawy, M. M., Barkat, M. A., Awaad, A. K., Thabet, E. H., Hamed, H. A., Elkafrawy, H., Khalil, N. A., Sallam, A., Kholief, M., et al. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i1.1 · Cited by 46
Zong, Y., Zhou, S., & Sorrentino, B. P. (2005) · Leukemia · doi:10.1038/sj.leu.2403853 · Cited by 44
Self-citationCancer Stem Cell-Like Side Population Cells in Clear Cell Renal Cell Carcinoma Cell Line 769P
Huang, B., Huang, Y., Yao, Z. J., Chen, X., Guo, S. J., Mao, X., Wang, D. H., Chen, J. X., & Qiu, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068293 · Cited by 44
Cygalova, L. H., Čečková, M., & Štaud, F. (2010) · Drug Metabolism Reviews · doi:10.3109/03602532.2010.512293 · Cited by 55
Lung cancer stem cells: a biological and clinical perspective
Koren, A., Motaln, H., & Čufer, T. (2013) · Cellular Oncology · doi:10.1007/s13402-013-0141-9 · Cited by 44
“ABCG2 • Breast cancer–resistance protein • ATP-binding cassette superfamily G-member 2 protein, superfamily of ABC transporters • Displays affinity for numerous cytotoxic molecules [25]”
BackgroundLichtenauer, U. D., Shapiro, I., Geiger, K. K., Quinkler, M. O., Faßnacht, M., Nitschke, R., Rückauer, K.-D., & Beuschlein, F. (2007) · Endocrinology · doi:10.1210/en.2007-1001 · Cited by 44
Habu, N., Imanishi, Y., Kameyama, K., Shimoda, M., Tokumaru, Y., Sakamoto, K., Fujii, R., Shigetomi, S., Otsuka, K., Sato, Y., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1732-9 · Cited by 49
“Enhanced multidrug resistance of SP cells is attributed to their overexpression of the various adenosine triphosphate (ATP)-binding cassette (ABC) transporter family members including ABCG2 (BCRP-1) [29–31].”
BackgroundSpitzwieser, M., Pirker, C., Koblmüller, B., Pfeiler, G., Hacker, S., Berger, W., Heffeter, P., & Cichna‐Markl, M. (2016) · Oncotarget · doi:10.18632/oncotarget.12332 · Cited by 45
“Increasing evidence suggests that ABCG2 is involved in MDR of cancer stem cells [19, 20].”
BackgroundInactivation of p38 MAPK contributes to stem cell-like properties of non-small cell lung cancer
Fang, Y., Wang, J., Wang, G., Zhou, C., Wang, P., Zhao, S., Zhao, S., HUANG, S. H., Su, W., Jiang, P., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15804 · Cited by 44
Biological principals and clinical potentials of limbal epithelial stem cells
Notara, M., & Daniels, J. T. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0458-7 · Cited by 44
Castellón, E. A., Valenzuela, R. B., Lillo, J., Castillo, V. M. D. P., Contreras, H. R., Iván Gallegos, M., Mercado, A., & Huidobro, C. (2012) · Biological Research · doi:10.4067/s0716-97602012000300011 · Cited by 44
Hanson, P. T., Mathews, V., Marrus, S. H., & Graubert, T. A. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(02)01021-4 · Cited by 49
Kadar, T., Horwitz, V., Sahar, R., Cohen, M., Cohen, L., Gez, R., Tveria, L., Gutman, H., Buch, H., Fishbine, E., et al. (2011) · Current Eye Research · doi:10.3109/02713683.2011.609305 · Cited by 44
Hematopoietic Stem Cell Characterization by Hoechst 33342 and Rhodamine 123 Staining
Bertoncello, I., & Williams, B. (2004) · Humana Press eBooks · doi:10.1385/1-59259-773-4:181 · Cited by 44
Kropski, J. A., Richmond, B. W., Gaskill, C. F., Foronjy, R., & Majka, S. M. (2017) · Pulmonary Circulation · doi:10.1177/2045893217739807 · Cited by 44
Wang, D., Patel, A. S., Shukla, S., Zhang, Y.-K., Wang, Y.-J., Kathawala, R. J., Robey, R. W., Zhang, L., Yang, D., Talele, T. T., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2102 · Cited by 43
“Recently, ABCG2 has been recognized as a molecular marker for the side population (SP) cells [7].”
Higher frequencies of BCRP+ cardiac resident cells in ischaemic human myocardium
Emmert, M. Y., Emmert, L. S., Martens, A., Ismail, I., Schmidt-Richter, I., Gawol, A., Seifert, B., Haverich, A., Martin, U., & Gruh, I. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs156 · Cited by 43
“Side population cells can be isolated by dualwavelength flow cytometry because of their capacity to efflux Hoechst dye, a process mediated by the ATP-binding cassette transporter breast cancer resistance protein (BCRP).(6,7) Breast cancer resistance protein (also known as ABCG2) has been recently reported to play a fu…”
BackgroundStem cells in endometrium and endometrial cancer: Accumulating evidence and unresolved questions
Kyo, S., Maida, Y., & Inoue, M. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.05.015 · Cited by 47
Identification of Cancer Stem-like Side Population Cells in Ovarian Cancer Cell Line OVCAR-3
Gao, Q., Geng, L., Kvalheim, G., Gaudernack, G., & Suo, Z. (2009) · Ultrastructural Pathology · doi:10.1080/01913120903086072 · Cited by 43
Bai, M., Shen, M., Teng, Y., Sun, Y., Fan, L., Zhang, X., Xu, Y., Duan, Y., & Du, L. (2015) · Oncotarget · doi:10.18632/oncotarget.6085 · Cited by 44
“Among ABC transporter family members, a novel protein, the breast cancer resistance protein (ABCG2), has been detected in a variety of malignancy tumors, such as breast cancer [7, 8].”
BackgroundEradicating Cancer Stem Cells: Concepts, Issues, and Challenges
Kaur, G., Sharma, P., Dogra, N., & Singh, S. (2018) · Current Treatment Options in Oncology · doi:10.1007/s11864-018-0533-1 · Cited by 43
“Side population (SP) has a characteristic to efflux the nucleic acid dye Hoechst 33,342 (binds to the AT-rich regions of the minor groove of DNA) through the expression of ATP-binding cassette protein (ABC) transporters [69].”
BackgroundFujishiro, T., Nonoguchi, N., Pavlyukov, M. S., Ohmura, N., Kawabata, S., Park, Y., Kajimoto, Y., Ishikawa, T., Nakano, I., & Kuroiwa, T. (2018) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2018.07.004 · Cited by 45
Kawai, N., Hirohashi, Y., Ebihara, Y., Saito, T., Murai, A., Saito, T., Shirosaki, T., Kubo, T., Nakatsugawa, M., Kanaseki, T., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216503 · Cited by 45
Özvegy‐Laczka, C., Laczkó, R., Hegedüs, C., Litman, T., Várady, G., Goda, K., Hegedűs, T., Dokholyan, N. V., Sorrentino, B. P., Váradi, A., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803230200 · Cited by 43
Self-citationQuiescent stem cells in the niche
Suda (2008) · StemBook · doi:10.3824/stembook.1.6.1 · Cited by 54
Drug Resistance and its Clinical Circumvention
Moscow, J. A., Cowan, K. H., & Sikic, B. I. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm063 · Cited by 44
Mishima, K., Inoue, H., Nishiyama, T., Mabuchi, Y., Amano, Y., Ide, F., Matsui, M., Yamada, H., Yamamoto, G., Tanaka, J., et al. (2012) · Stem Cells · doi:10.1002/stem.1173 · Cited by 42
Detection of Hematopoietic Stem Cells by Flow Cytometry
Lin, K., & Goodell, M. A. (2011) · Methods in cell biology · doi:10.1016/b978-0-12-385493-3.00002-4 · Cited by 44
Pierre-Louis, O., Clay, D., de la Grange, P. B., Blazsek, I., Desterke, C., Guerton, B., Blondeau, C., Malfuson, J., Prat, M., Griscelli, A. B., et al. (2009) · Stem Cells · doi:10.1002/stem.186 · Cited by 49
Cervical cancer stem cells manifest radioresistance: Association with upregulated AP-1 activity
Tyagi, A., Vishnoi, K., Kaur, H., Srivastava, Y., Roy, B. G., Das, B. C., & Bharti, A. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-05162-x · Cited by 42
Therapeutic Delivery of Tumor Suppressor miRNAs for Breast Cancer Treatment
Shinde, S., Ahmed, S., Malik, J. A., Hani, U., Khanam, A., Bhat, F. A., Mir, S. A., Ghazwani, M., Wahab, S., Haider, N., et al. (2023) · Biology · doi:10.3390/biology12030467 · Cited by 46
“Many PGP substra es quickly separate into lipids and plasma me branes and are n cessary for medication-stimulated ATPase activi y [49].”
BackgroundPutative cancer stem cells in cutaneous malignancies
Kamstrup, M. R., Gniadecki, R., & Skovgaard, G. L. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00547.x · Cited by 45
High Cloning Capacity of In Vitro Packaged SV40 Vectors with No SV40 Virus Sequences
Kimchi‐Sarfaty, C., Arora, M., Sandalon, Z., Oppenheim, A., & Gottesman, M. M. (2003) · Human Gene Therapy · doi:10.1089/104303403321070865 · Cited by 43
Heterogeneic nature of adult cardiac side population cells
Yamahara, K., Fukushima, S., Coppen, S. R., Felkin, L. E., Varela‐Carver, A., Barton, P. J. R., Yacoub, M. H., & Suzuki, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.021 · Cited by 42
Liu, C.-M., Chang, C., Yu, C.-H., Hsu, C., & Huang, L. L. H. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0780-3 · Cited by 41
Prostate cancer stem cells: Are they androgen-responsive?
Oldridge, E. E., Pellacani, D., Collins, A. T., & Maitland, N. J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.008 · Cited by 60
Skoglund, K., Moreno, S. B., Jönsson, J., Vikingsson, S., Carlsson, B., & Gréen, H. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000022 · Cited by 43
“characterized [20, 21].”
Fluctuation of the SP/non‐SP phenotype in the C6 glioma cell line
Platet, N., Mayol, J.-F., Berger, F. R., Hérodin, F., & Wion, D. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.071 · Cited by 41
Xu, D.-D., Zhou, P.-J., Wang, Y., Zhang, L., Fu, W.-Y., Ruan, B.-B., Hu, C.-Z., Hu, C.-Z., Tian, L., Qin, J., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0521-7 · Cited by 43
“Side population cell sorting technology is widely used to identify cancer stem cell-like cells in cancer, and the ABC transporter family member ABCG2 is an unfavorable prognostic factor in ESCC [50–52].”
BackgroundXiang, Y., Yang, T., Pang, B.-Y., Zhu, Y., & Liu, Y. (2016) · Stem Cells International · doi:10.1155/2016/7614971 · Cited by 42
“Further study explored the mechanism of ABCG2 expression in HCC, demonstrating by altering the subcellular localization of ABCG2 that the Akt pathways regulated the SP phenotype activity and the ABCG2-induced chemotherapy resistance could be resisted via inhibited Akt signaling [93, 96].”
Pouyafar, A., Rezabakhsh, A., Rahbarghazi, R., Heydarabad, M. Z., Shokrollahi, E., Sokullu, E., Khaksar, M., Nourazarian, A., & Avcı, Ç. B. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-02998-9 · Cited by 41
“One explanation would be that the expression of anti-apoptotic factors and ABC transporters is highly conserved in CSCs as compared with normal stem cells or neighboring cancer cells (Zhou et al. 2001).”
BackgroundLi, Y., Zhou, R., Xiao, D., Shi, S., Peng, S., Wu, S., Wu, P., & Lin, Y. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.126344 · Cited by 42
Bram, E. E., Ifergan, I., Grimberg, M., Lemke, K., Składanowski, A., & Assaraf, Y. G. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.03.028 · Cited by 41
Shibata, F., Goto-Koshino, Y., Morikawa, Y., Komori, T., Ito, M., Fukuchi, Y., Houchins, J. P., Tsang, M., Li, D. Y., Kitamura, T., et al. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0292 · Cited by 41
Modeling Human Hematopoietic Stem Cell Biology in the Mouse
Sykes, S. M., & Scadden, D. T. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.03.029 · Cited by 48
“For example, the exclusion or extrusion of dyes such as rhodamine or Hoescht33342 was noted to be a property of the mouse HSC and attributed to differential ABC transporter activity.(18,21) This led to a highly useful means of isolating HSCs in mouse based on a so-termed ‘‘side population’’ when FACS sorting Hoescht33…”
Telbisz, Á., Hegedüs, C., Özvegy‐Laczka, C., Goda, K., Várady, G., Takáts, Z., Szabó, E., Sorrentino, B. P., Váradi, A., & Sarkadi, B. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.10.021 · Cited by 43
“The ABCG2 protein is present in several normal tissues and in stem cells, and its overexpression has also been documented in drug-resistant cell lines and tumors turning them to amore resistant phenotype against several anticancer drugs (Maliepaard et al., 2001; Zhou et al., 2001; Sarkadi et al., 2006).”
BackgroundSelf-citationXanthines Down-Regulate the Drug Transporter ABCG2 and Reverse Multidrug Resistance
Ding, R., Shi, J., Pabon, K., & Scotto, K. W. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.075556 · Cited by 41
Stem cells of the human cornea
Girolamo, N. D. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr026 · Cited by 42
van der Heijden, J., de Jong, M. C., Dijkmans, B. A. C., Lems, W. F., Oerlemans, R., Kathmann, I., Scheffer, G. L., Scheper, R. J., Assaraf, Y. G., & Jansen, G. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.006494 · Cited by 46
Sen, U., Sudheer Shenoy, P., & Bose, B. (2017) · Cell Biology International · doi:10.1002/cbin.10830 · Cited by 40
“Such chemoresistance is attributed to various features of CSCs such as presence of ABC transporter proteins for effluxing the drug (Zhou et al. 2001; Lou and Dean, 2007; Hao et al., 2010; Gatti et al., 2011; Shafi and Jabeen, 2017); presence of prosurvival protein BCL2 and associated proteins such as BCL-XL, BCL-W, BC…”
Stem Cells in Endometrial Physiology
Gurung, S., Deane, J., Masuda, H., Maruyama, T., & Gargett, C. (2015) · Seminars in Reproductive Medicine · doi:10.1055/s-0035-1558405 · Cited by 41
Detection and characterization of side population in Ewing’s sarcoma SK-ES-1 cells in vitro
Yang, M. H., Zhang, R., Yan, M., Ye, Z., Liang, W., & Luo, Z. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.020 · Cited by 43
Zheng, X., Naiditch, J. A., Czurylo, M., Jie, C., Lautz, T. B., Clark, S. H., Jafari, N., Qiu, Y.-Y., Chu, F., & Madonna, M. B. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.264 · Cited by 40
Yang, W., Song, M.-J., Park, E. Y., Lee, J.-J., Park, J., Park, K., Park, J. H., & Kim, H. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0191-x · Cited by 40
Selbo, P. K., Bostad, M., Olsen, C. E., Edwards, V. T., Høgset, A., Weyergang, A., & Berg, K. (2015) · Photochemical & Photobiological Sciences · doi:10.1039/c5pp00027k · Cited by 41
Tissue-Regenerating, Vision-Restoring Corneal Epithelial Stem Cells
Echevarria, T. J., & Girolamo, N. D. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9199-1 · Cited by 43
“ABCG2 is responsible for effluxing dyes such as Hoechst 33342 [33] and is commonly observed in ‘side population’ cells which have phenotypic and functional features of SCs.”
BackgroundImai, Y., Yoshimori, M., Fukuda, K., Yamagishi, H., & Ueda, Y. (2012) · Oncology Reports · doi:10.3892/or.2012.1724 · Cited by 45
“BCRP is a molecular determinant of side-population (SP) cells, which are enriched in various stem cells (16).”
Xu, J., Morii, E., Liu, Y., Nakamichi, N., Ikeda, J., Kimura, H., & Aozasa, K. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.03.006 · Cited by 40
Identification of Inhibitors of ABCG2 by a Bioluminescence Imaging–Based High-Throughput Assay
Zhang, Y., Byun, Y., Ren, Y. R., Liu, J. O., Laterra, J., & Pomper, M. G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4866 · Cited by 40
Sorting and identification of side population cells in the human cervical cancer cell line HeLa
Qi, W., Zhao, C., Zhao, L., Liu, N., Li, X., Yu, W., & Wei, L. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-3 · Cited by 40
“The expression of ABCG2/BCRP1 shows a strong positive correlation with the phenotype of SP cells in a series of studies, which is the molecular basis of the phenotypic characteristics of SP cells [12].”
Role of Breast Cancer Resistance Protein in the Adaptive Response to Cholestasis
Mennone, A., Soroka, C. J., Harry, K., & Boyer, J. L. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.034512 · Cited by 43
Pustovalova, M. V., Alhaddad, L., Smetanina, N. M., Chigasova, A. K., Blokhina, T., Chuprov‐Netochin, R. N., Osipov, A. N., & Leonov, S. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093342 · Cited by 46
“The ABCG2 is a suggested molecular determinant of the side population (SP) phenotype, and the expression of ABCG2 mRNA was markedly higher in SP for all lung cancer cell lines analyzed [27].”
Backgroundde la Cruz‐Merino, L., Lejeune, M., Fernández, E. N., Henao, F., López, A. G., Illescas-Vacas, A., Provencio, M., Callau, C., & Álvaro, T. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/756353 · Cited by 43
“These SP cells also express multidrug transporter proteins, including MDR1 and ABCG2 [87, 88], which not only efflux Hoechst dye but also rapidly reduce the intracellular concentrations and thus the cytotoxicity of many commonly used therapeutic drugs [89, 90].”
BackgroundImplications of Cancer Stem Cells In the Treatment of Cancer
Pan, C.-X., Zhu, W. P., & Liang Cheng, C. (2006) · Future Oncology · doi:10.2217/14796694.2.6.723 · Cited by 41
Haslam, I. S., Chami, C. E., Faruqi, H., Shahmalak, A., O’Neill, C. A., & Paus, R. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13549 · Cited by 40
Hepatocyte progenitors in man and in rodents – multiple pathways, multiple candidates
Laurson-Doube, J., Selden, C., & Hodgson, H. J. F. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00410.x · Cited by 40
Liadaki, K. N., Kho, A. T., Sanoudou, D., Schienda, J., Flint, A., Beggs, A. H., Kohane, I. S., & Kunkel, L. M. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.10.011 · Cited by 39
Environmental exposure and the role of AhR in the tumor microenvironment of breast cancer
Sweeney, C. A., Lazennec, G., & Vogel, C. F. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1095289 · Cited by 43
“MDR is due in part to robust expression of the ABCG2 efflux protein, also known as Breast Cancer Resistance Protein (BCRP) (Zhou et al., 2001; Zattoni et al., 2022), a direct transcriptional target of AhR (Tan et al.”
BackgroundHu, Y.-P., Tao, L.-Y., Wang, F., Zhang, J., Liang, Y.-J., & Fu, L. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.04.003 · Cited by 39
ZHANG, H., Yu, T., Wen, L., Wang, H., FEI, D., & Jin, C. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1297 · Cited by 39
“The ATP-binding cassette transporter, ABCG2, functions as an ATP-dependent drug efflux pump contributing to drug resistance (16,17) and is highly expressed in cells with a side population phenotype (18).”
Metadata
- Authors
- Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., & Sorrentino, B. P.
- Affiliations
- St. Jude Children's Research Hospital (US)
- University of Tsukuba (JP)
- Corresponding author
- Sorrentino, Brian P.
- ORCID
- Venue
- Nature Medicine
- Published
- 2001-09
- Volume
- 7
- Issue
- 9
- Pages
- 1028-1034
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1483167997
- Cited by
- 2,280
- References
- 37
- Citations by year
- 2026: 9 · 2025: 25 · 2024: 28 · 2023: 53 · 2022: 43 · 2021: 44 · 2020: 63 · 2019: 58 · 2018: 72 · 2017: 90 · 2016: 82 · 2015: 100 · 2014: 117 · 2013: 146 · 2012: 142
- FWCI
- 34.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL053749, P01HL53749, R01HL067366, R01-HL67366-01)
- National Cancer Institute (P 30CA 21765, P30CA021765)
- National Institute of General Medical Sciences (GM60904)
- National Institute of Environmental Health Sciences (ES05851)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- ABCG2, BCRP1, ABC transporters, side population cells, stem cells, hematopoietic stem cells, bone marrow, skeletal muscle stem cells, stem cell markers, stem cell differentiation, stem cell transplantation, drug efflux
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily G, Member 2, Animals, Bone Marrow Cells, Cells, Cultured, Female, Humans, Male, Membrane Glycoproteins, Mice, Inbred Strains, Mice, Mutant Strains, Neoplasm Proteins, Ribosomal Proteins, Stem Cells, Biomarkers, Antigens, CD, Cytokines, ATP-Binding Cassette Transporters, Antigens, CD34, Macrophage Inflammatory Proteins, Transplants, Chemokines, CC, ATP Binding Cassette Transporter, Subfamily B, Member 1, ATP-Binding Cassette, Sub-Family C Proteins, Mice, Tetraspanin 29
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.